Kura Oncology (KURA) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.75% |
| Dec 31, 2025 | 8.27% |
| Sep 30, 2025 | -20.73% |
| Jun 30, 2025 | -28.32% |
| Mar 31, 2025 | -24.87% |
| Dec 31, 2024 | -71.57% |
| Sep 30, 2024 | -0.60% |
| Jun 30, 2024 | -3.05% |
| Mar 31, 2024 | -29.86% |
| Dec 31, 2023 | 3.20% |
| Sep 30, 2023 | -5.80% |
| Jun 30, 2023 | -5.93% |
| Mar 31, 2023 | 15.45% |
| Dec 31, 2022 | 15.44% |
| Sep 30, 2022 | 21.28% |
| Jun 30, 2022 | 20.66% |
| Mar 31, 2022 | 20.50% |
| Dec 31, 2021 | 18.22% |
| Sep 30, 2021 | -67.00% |
| Jun 30, 2021 | -67.47% |
| Mar 31, 2021 | -178.37% |
| Dec 31, 2020 | -167.35% |
| Sep 30, 2020 | -30.10% |
| Jun 30, 2020 | -29.63% |
| Mar 31, 2020 | -31.06% |
| Dec 31, 2019 | -32.35% |
| Sep 30, 2019 | -33.46% |
| Jun 30, 2019 | -107.66% |
| Mar 31, 2019 | -19.77% |
| Dec 31, 2018 | -92.16% |
| Sep 30, 2018 | -85.93% |
| Jun 30, 2018 | -136.43% |
| Mar 31, 2018 | -133.63% |
| Dec 31, 2017 | -37.40% |
| Sep 30, 2017 | -35.19% |
| Jun 30, 2017 | 33.52% |
| Mar 31, 2017 | 20.33% |
| Dec 31, 2016 | 20.94% |
| Sep 30, 2016 | -80.85% |
| Jun 30, 2016 | -74.36% |
| Mar 31, 2016 | -38.60% |
| Dec 31, 2015 | -7,528.65% |
| Sep 30, 2015 | -50,182.93% |
| Jun 30, 2015 | -933,877.23% |
| Mar 31, 2015 | -868,431.13% |
| Dec 31, 2014 | -17,013.28% |
| Sep 30, 2014 | -675.05% |
| Jun 30, 2014 | 73.71% |
| Mar 31, 2014 | -112.62% |
| Dec 31, 2013 | -36.78% |
| Sep 30, 2013 | -89.40% |
| Jun 30, 2013 | -97.29% |
| Mar 31, 2013 | 87.78% |
| Dec 31, 2012 | -13.79% |
| Sep 30, 2012 | 9.24% |
| Jun 30, 2012 | -2.44% |
| Mar 31, 2012 | -462.63% |
| Dec 31, 2011 | 84.31% |
| Sep 30, 2011 | -173.07% |